Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology
- 14 January 2003
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 328 (1-2) , 45-58
- https://doi.org/10.1016/s0009-8981(02)00376-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Time-Resolution in Fluorometry Technologies, Labels, and Applications in Bioanalytical AssaysCritical Reviews in Clinical Laboratory Sciences, 2001
- USE OF THE COMPLEX BETWEEN PROSTATE SPECIFIC ANTIGEN AND α1-PROTEASE INHIBITOR FOR SCREENING PROSTATE CANCERJournal of Urology, 2000
- Prostate-specific antigenSeminars in Cancer Biology, 1999
- Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modelingProtein Science, 1998
- In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α1-antichymotrypsin in blood samplesUrology, 1996
- Production of Recombinant PSA and HK2 and Analysis of Their Immunological Cross-ReactivityBiochemical and Biophysical Research Communications, 1995
- Time-resolved detection of lanthanide luminescence for ultrasensitive bioanalytical assaysJournal of Photochemistry and Photobiology B: Biology, 1995
- Enzyme-amplified lanthanide luminescence for enzyme detection in bioanalytical assaysAnalytical Biochemistry, 1991
- Streptavidin-based macromolecular complex labeled with a europium chelator suitable for time-resolved fluorescence immunoassay applicationsAnalytical Chemistry, 1990
- Europium as a label in time-resolved immunofluorometric assaysAnalytical Biochemistry, 1984